All regulations
Nonrulemaking
FDA
Open for Comments
FDA-2024-D-2033
Expedited Program for Serious Conditions--Accelerated Approval of Drugs and Biologics; Draft Guidance for Industry; Availability
Documents
6
Comments
49
Key Dates
Comment Period OpensDec 6, 2024
Comment Period ClosesApr 8, 2026
Documents
Comment Statistics
Total Comments
49
Keywords
2024-43
CDER
CBER
OCE
Expedited Program for Serious Conditions
Accelerated Approval of Drugs and Biologics
Draft Guidance for Industry
Availability
OPEN
Data from Regulations.gov